Oct 26, 2026

  • Add News

Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%

The government has announced a cap on trade margins for non-scheduled anti-cancer drugs at 30%. This move is expected to lower the prices of cancer medications by 20 to 70%. Officials anticipate substantial annual savings for patients reaching approximately ₹2,500 crore. The initiative aims to enhance affordability and accessibility while curbing excessive trade markups. Concerns have been raised regarding the effectiveness of such measures in making treatments affordable.

RSS News
Economic times

0 thoughts on “Cancer drugs may get up to 70% cheaper as govt fixes trade margins on non-scheduled medicines at 30%”

Leave a Reply

Your email address will not be published. Required fields are marked *

We use cookies to ensure that we give you the best experience on our website. By continuing to browse our site we'll assume that you understand this. Learn more